Skip to main navigation
Solid Biosciences

IR Navigation

  • Overview
  • News & Events
    • Press Releases
    • Presentations
    • Events
  • Governance
    • Governance Documents
    • Committee Charters
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Annual Report & Proxy Materials
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
  • Investor Resources
    • Investor FAQs
    • Contact Solid Biosciences
    • Email Alerts
« Solidbio.com

News & Events

Events

More events are coming soon.
Past Events
  • Jan 12 12:00 PM EST

    41st Annual J.P. Morgan Healthcare Conference

    Listen to Webcast
  • Dec 1 10:30 AM EST

    Piper Sandler 34th Annual Healthcare Conference

    Listen to Webcast
  • Oct 4 1:00 PM EDT

    Chardan's 6th Annual Genetic Medicines Conference

    Listen to Webcast
  • Sep 30 3:00 PM EDT

    Jefferies Cell and Genetic Medicine Summit

    Listen to Webcast
  • Sep 30 8:00 AM EDT

    Solid Biosciences Strategic Business Update Conference Call

    Listen to Webcast
  • Jun 10 10:30 AM EDT

    Jefferies Healthcare Conference

    Listen to Webcast
  • Apr 27 8:00 AM EDT

    Solid Biosciences First Quarter 2022 Financial Results Call

    Listen to Webcast
  • Feb 17 4:20 PM EST

    SVB Leerink 11th Annual Global Healthcare Conference

    Listen to Webcast
  • Jan 13 9:00 AM EST

    40th Annual J.P. Morgan Healthcare Conference

    Listen to Webcast

Footer Links

  • Contact Us
  • Privacy
  • Terms and Conditions

© 2023 Solid Biosciences Inc. All rights reserved.

Solid Biosciences Inc., is a Charlestown, MA-based life science company committed to solving Duchenne muscular dystrophy and improving the lives of patients. Solid is currently developing gene therapies, disease modifying therapies and assistive devices, all targeting the many facets of the disease.

The characterization of the discovery and development efforts on this website, as well as the expectations associated with them, are reflective of the current state of development and may change as the Company progresses.